Literature DB >> 32577104

Low Serum Albumin Levels are Associated with Increased 30-Day Cardiopulmonary Complications, Reoperation, and Readmission Rates Following Total Shoulder Arthroplasty.

Danny Lee1, Ryan Lee1, Megan T Cross1, Andrew Tran2, Jason Kappa2, Sam Moghtaderi2.   

Abstract

Background: Hypoalbuminemia has been associated with several medical complications following surgery in a variety of orthopedic procedures. Hypoalbuminemia has previously been shown to have an increased risk for transfusions, hospital stay longer than three days, and mortality following total shoulder arthroplasty (TSA). This study seeks to further assess the relationship between low serum albumin and morbidity to allow surgeons to both preoperatively optimize patients and assess the risk of surgery prior to TSA.
Methods: The American College of Surgeons National Surgical Quality Improvement Program® database was queried to identify 14,494 TSA patients, 6,129 (42.23%) who met inclusion criteria. Patients who had shoulder hemiarthroplasty, revision TSA, or incomplete serum albumin data were excluded. Demographic factors, preoperative comorbidities, and acute complication rates were assessed between hypoalbuminemic (n=485; 7.91%) and a propensity-matched control cohort (n=485), controlling for differences in patient demographics and comorbidities. Multivariate propensity-adjusted logistic regression analyses were used to assess hypoalbuminemia as an independent risk factor for specific postoperative complications.
Results: Hypoalbuminemic patients undergoing TSA demonstrated significantly higher rates of pulmonary complications (p=0.006), unplanned intubation (p=0.014), DVT/PE (p=0.014), cardiac complications (p=0.033), infectious complications (p=0.025), blood transfusions (p<0.001), reoperation (p=0.007), extended length of stay (> 4 days) (p=0.036), unplanned readmission (p=0.001), and mortality (p=0.025) in the 30-day postoperative period when compared to the propensity-matched control cohort. On multivariate regression analyses, hypoalbuminemia independently increased the risk for pulmonary complications (OR 9.678, p=0.031), blood transfusions (OR 2.539, p<0.001), reoperation (OR 5.461, p=0.032), and readmission (OR 2.607, p=0.007). Conclusions: Hypoalbuminemic patients undergoing TSA had increased rates of overall cardiac and pulmonary complications, unplanned intubations, DVT/PE's, overall infectious complications, increased incidence of blood transfusions, reoperation, extended LOS (> 4 days), readmission, and death. Multivariate analyses demonstrated that low albumin was independently associated with increased risk for pulmonary complications, blood transfusions, reoperation, and readmission. Preoperative albumin levels in patients undergoing TSA may help with preoperative risk stratification and optimization.Level of evidence: III.
Copyright © The Iowa Orthopaedic Journal 2019.

Entities:  

Keywords:  albumin; blood transfusion; cardiac; complication; hypoalbuminemia; mortality; pulmonary; readmission; reoperation; total shoulder arthroplasty; unplanned intubation

Year:  2019        PMID: 32577104      PMCID: PMC7047290     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  35 in total

1.  Increasing incidence of shoulder arthroplasty in the United States.

Authors:  Sunny H Kim; Barton L Wise; Yuqing Zhang; Robert M Szabo
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

Review 2.  Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.

Authors:  D K Galanakis
Journal:  Semin Thromb Hemost       Date:  1992-01       Impact factor: 4.180

3.  Perioperative complications after hemiarthroplasty and total shoulder arthroplasty are equivalent.

Authors:  Edward Shields; James C Iannuzzi; Robert Thorsness; Katia Noyes; Ilya Voloshin
Journal:  J Shoulder Elbow Surg       Date:  2014-04-18       Impact factor: 3.019

4.  Histone induced platelet aggregation is inhibited by normal albumin.

Authors:  Fong W Lam; Miguel A Cruz; Hon-Chiu E Leung; Kathan S Parikh; C Wayne Smith; Rolando E Rumbaut
Journal:  Thromb Res       Date:  2013-05-11       Impact factor: 3.944

5.  Understanding the statistics and limitations of large database analyses.

Authors:  Hiroyuki Yoshihara; Daisuke Yoneoka
Journal:  Spine (Phila Pa 1976)       Date:  2014-07-15       Impact factor: 3.468

6.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Authors:  J Danesh; R Collins; P Appleby; R Peto
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

7.  Total Shoulder Arthroplasty Demographics, Incidence, and Complications-A Nationwide Inpatient Sample Database Study.

Authors:  Kimona Issa; Casey M Pierce; Todd P Pierce; Matthew R Boylan; Bashir A Zikria; Qais Naziri; Anthony Festa; Vincent K McInerney; Anthony J Scillia
Journal:  Surg Technol Int       Date:  2016-10-26

Review 8.  Human serum albumin in the clinical syndrome of heart failure.

Authors:  Stephane Arques; Pierre Ambrosi
Journal:  J Card Fail       Date:  2011-04-22       Impact factor: 5.712

9.  Hypoalbuminemia Is an Independent Risk Factor for 30-Day Mortality, Postoperative Complications, Readmission, and Reoperation in the Operative Lower Extremity Orthopaedic Trauma Patient.

Authors:  Jacob M Wilson; Matthew P Lunati; Zachary J Grabel; Christopher A Staley; Andrew M Schwartz; Mara L Schenker
Journal:  J Orthop Trauma       Date:  2019-06       Impact factor: 2.512

10.  Albumin and surgical site infection risk in orthopaedics: a meta-analysis.

Authors:  Peizhi Yuwen; Wei Chen; Hongzhi Lv; Chen Feng; Yansen Li; Tao Zhang; Pan Hu; Jialiang Guo; Ye Tian; Lei Liu; Jiayuan Sun; Yingze Zhang
Journal:  BMC Surg       Date:  2017-01-16       Impact factor: 2.102

View more
  1 in total

1.  Prevalence and risk factors of preoperative deep venous thrombosis in closed patella fracture: a prospective cohort study.

Authors:  Zhanchao Tan; Hongzhi Hu; Zhongzheng Wang; Yuchuan Wang; Yingze Zhang
Journal:  J Orthop Surg Res       Date:  2021-06-23       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.